• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟苯尼考-氧化苦参碱共无定形系统提高氟苯尼考的溶解度和溶出速率:制备、表征和分子动力学模拟。

Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.

机构信息

School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China.

School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China.

出版信息

J Pharm Sci. 2021 Jun;110(6):2544-2554. doi: 10.1016/j.xphs.2021.02.005. Epub 2021 Feb 9.

DOI:10.1016/j.xphs.2021.02.005
PMID:33577826
Abstract

Coamorphous system has proved to be an effective approach to improve the solubility of BCSⅡ drugs. Florfenicol (FF) is a widely used veterinary antibiotic but has poor aqueous solubility. Therefore, the coamorphous system of florfenicol and oxymatrine (OMT) formulated at 1:1 and 1:2 M ratios were prepared by using solvent evaporation, followed by a series of characterization in terms of PXRD, DSC, FTIR and Raman spectroscopy. It was found that FF and OMT are miscible according to Hansen solubility parameters. The molecular electrostatic potential (MEP) and radial distribution function (RDF) analysis demonstrated the possible hydrogen bond interaction in coamorphous system, which was confirmed by FTIR and Raman spectra. The coamorphous FF-OMT (1:1) maintained stability for 60 days at 25 °C/0% RH and 30 days at 40 °C/75% RH, which may be attributed to better molecular miscibility of FF and OMT and the strong hydrogen bond of O-H (FF)⋯O-N (OMT) and N-H (FF)⋯O-N (OMT). In addition, the apparent solubility and permeability, dissolution and intrinsic dissolution rate (IDR) of the acquired coamorphous solids were obviously increased compared with crystalline FF. In conclusion, a drug-drug coamorphous formulation can be applied to improve the solubility and dissolution of crystalline FF.

摘要

无定形系统已被证明是提高 BCSⅡ类药物溶解度的有效方法。氟苯尼考(FF)是一种广泛应用于兽医的抗生素,但水溶性差。因此,采用溶剂蒸发法制备了氟苯尼考和氧化苦参碱(OMT)以 1:1 和 1:2 M 比例形成的共无定形系统,并通过粉末 X 射线衍射(PXRD)、差示扫描量热法(DSC)、傅里叶变换红外光谱(FTIR)和拉曼光谱对其进行了一系列的表征。根据 Hansen 溶解度参数,发现 FF 和 OMT 是可混溶的。分子静电势(MEP)和径向分布函数(RDF)分析表明共无定形系统中可能存在氢键相互作用,这通过 FTIR 和拉曼光谱得到了证实。FF-OMT(1:1)共无定形物在 25°C/0%RH 下稳定 60 天,在 40°C/75%RH 下稳定 30 天,这可能归因于 FF 和 OMT 更好的分子混合性以及 O-H(FF)⋯O-N(OMT)和 N-H(FF)⋯O-N(OMT)的强氢键。此外,与结晶 FF 相比,获得的共无定形固体的表观溶解度和渗透性、溶出度和固有溶出速率(IDR)明显提高。总之,药物-药物共无定形制剂可用于提高结晶 FF 的溶解度和溶出度。

相似文献

1
Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.氟苯尼考-氧化苦参碱共无定形系统提高氟苯尼考的溶解度和溶出速率:制备、表征和分子动力学模拟。
J Pharm Sci. 2021 Jun;110(6):2544-2554. doi: 10.1016/j.xphs.2021.02.005. Epub 2021 Feb 9.
2
Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.基于分子动力学和光谱学探究混晶穿心莲内酯-氧化苦参碱的形成机制。
J Pharm Sci. 2022 Jul;111(7):2056-2071. doi: 10.1016/j.xphs.2022.02.003. Epub 2022 Feb 12.
3
Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.三招并用,将熊果酸制成共无定形物,提升其口服生物利用度:提高水溶性、渗透性,抑制细胞色素 P450 同工酶。
Mol Pharm. 2020 Dec 7;17(12):4443-4462. doi: 10.1021/acs.molpharmaceut.0c00443. Epub 2020 Nov 9.
4
A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.一种无分子相互作用的新型药物共非晶体系:改善他达拉非和瑞格列奈的物理化学性质。
RSC Adv. 2020 Jan 2;10(1):565-583. doi: 10.1039/c9ra07149k. eCollection 2019 Dec 20.
5
Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.具有增强的物理稳定性和生物利用度的洛沙平-柠檬酸共无定形系统。
AAPS PharmSciTech. 2017 Oct;18(7):2541-2550. doi: 10.1208/s12249-017-0734-0. Epub 2017 Feb 21.
6
Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.制备并表征利福平共无定形物与三羟甲基氨基甲烷共晶形成剂:实验-理论研究。
Mol Pharm. 2024 Mar 4;21(3):1272-1284. doi: 10.1021/acs.molpharmaceut.3c00947. Epub 2024 Feb 15.
7
Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.将络合作用纳入共无定形系统可显著提高无定形盐酸鲁拉西酮的溶解性能并消除其胶凝作用。
Mol Pharm. 2020 Jan 6;17(1):84-97. doi: 10.1021/acs.molpharmaceut.9b00772. Epub 2019 Dec 16.
8
Enhancement of dissolution rate and oral bioavailability of poorly soluble drug florfenicol by using solid dispersion and effervescent disintegration technology.利用固体分散体和泡腾崩解技术提高难溶性药物氟苯尼考的溶出速率和口服生物利用度。
Drug Dev Ind Pharm. 2024 Jan;50(1):45-54. doi: 10.1080/03639045.2023.2295488. Epub 2024 Jan 30.
9
Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.无定形药物系统:增强吲哚美辛和萘普生的物理稳定性和溶解速率。
Mol Pharm. 2011 Oct 3;8(5):1919-28. doi: 10.1021/mp2002973. Epub 2011 Aug 15.
10
Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.共形态物形成与络合作用增强了盐酸鲁拉西酮和葛根素的溶解,并实现了同步释放。
Int J Pharm. 2020 Oct 15;588:119793. doi: 10.1016/j.ijpharm.2020.119793. Epub 2020 Aug 19.

引用本文的文献

1
Recent Advances in Coamorphous Systems of Natural Active Pharmaceutical Ingredients: Preparations, Characterizations, and Applications.天然活性药物成分共无定形体系的研究进展:制备、表征及应用
ACS Omega. 2025 Aug 5;10(32):35352-35366. doi: 10.1021/acsomega.5c03834. eCollection 2025 Aug 19.
2
Cutting-Edge Approaches in the Co-Amorphization Process.共非晶化过程中的前沿方法。
Pharmaceutics. 2025 Jun 29;17(7):850. doi: 10.3390/pharmaceutics17070850.
3
A New Screening Strategy for Flavonoid Components to Obtain a Satisfactory Co-Amorphous System with Piperine.
一种用于黄酮类成分的新筛选策略,以获得与胡椒碱的令人满意的共无定形体系。
AAPS PharmSciTech. 2025 Mar 5;26(3):78. doi: 10.1208/s12249-025-03077-9.
4
A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study.用于显著提高灯盏花素溶解度的药物-药物共无定形体系:一项实验与计算研究
Sci Rep. 2024 Dec 28;14(1):31183. doi: 10.1038/s41598-024-82524-2.
5
Recent Advances in Co-Former Screening and Formation Prediction of Multicomponent Solid Forms of Low Molecular Weight Drugs.低分子量药物多组分固体形式的共成型剂筛选与晶型预测的最新进展
Pharmaceutics. 2023 Aug 22;15(9):2174. doi: 10.3390/pharmaceutics15092174.
6
Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.共无定形药物递送系统:物理稳定性、体外和体内性能的综述。
AAPS PharmSciTech. 2022 Sep 19;23(7):259. doi: 10.1208/s12249-022-02421-7.
7
Sustained Release of Co-Amorphous Matrine-Type Alkaloids and Resveratrol with Anti-COVID-19 Potential.具有抗COVID-19潜力的共无定形苦参类生物碱与白藜芦醇的缓释
Pharmaceutics. 2022 Mar 10;14(3):603. doi: 10.3390/pharmaceutics14030603.